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COMMENTARY
Theodore R. Marmor*
THE HISTORY of medicine in the United States over the pastfifteen years has been one of terribly confusing change. In 1971,
Senator Edward Kennedy and his aides wrote a book about the
world of American medical care entitled In Critical Condition: The
Crisis in America's Health Care.' The sense of trouble typified by
this book was so widespread that both Republicans and Democrats,
liberals and conservatives, competed over which form of national
health insurance to enact. In 1974, for instance, the now forgotten
Kennedy-Mills proposal received extended consideration in the fi-
nance committees of the Congress, as did the Nixon CHIP plan and
the catastrophic health insurance bill of Senators Long and Ribi-
coff. It all seems very long ago, looking back from the Reagan era,
this flurry of proposals and stalemate over universal government
health insurance.2
In 1986, the picture is much different, both politically and intel-
lectually. No one of political significance is directly advocating uni-
versal health insurance, either for the nation or for a particular
state. Politically, the deficits of the first Reagan administration
dominate political discourse and severely limit the practical and re-
alistic scope of discussion. Intellectually, we are living with the
debris of the reform mentality of the 1970's.
In medicine, that reform mentality resulted in a morass of gov-
ernmental interventions, each certain to disappoint standing alone,
but yet collectively regarded as a group of incremental steps toward
sensible governmental intervention in the financing of health serv-
ices. The regulation that in fact emerged was bureaucratically dis-
persed, disconnected from the major financing of care, and
celebrated with visions of eventual success no reasonable analyst
* Professor of Public Management and Political Science, Yale University. B.A.,
Harvard College (1960); Graduate Research Fellow, Wadham College, Oxford (1961-62);
Ph.D., Harvard University (1966).
1. E. KENNEDY, IN CRITICAL CONDITION: THE CRISIS IN AMERICA'S HEALTH
CARE (1972).
2. The politics of this period are reviewed in both L. BROWN, POLITICS AND HEALTH
CARE ORGANIZATION: HMOS AS FEDERAL POLICY (1984); and T.R. MARMOR, POLITICAL
ANALYSIS AND AMERICAN MEDICAL CARE (1983).
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should have accepted. A new form of health planning emerged in
1974. Two hundred and five little agencies were established all over
the country, equipped with the authority to veto major capital ex-
pansion, but not equipped with a financial carrot to induce anyone
to affirmatively do very much but rush to the state legislature or to
the courts to protect planning restraints. Professional Standards
Review Organizations (PSROs)-programs to monitor quality of
care-were given in 1972 to yet another set of agencies, dominated
by physicians and disconnected in practice from Medicare, Medi-
caid, or the commercial and nonprofit health insurance plans.
Medicare and Medicaid, once separate entities, were in 1977 techni-
cally fused into what is now known as HCFA, the Health Care Fi-
nancing Agency of the Department of Health and Human Services.
All through the decade observers complained about the rela-
tively high rates of inflation in medicine, but little was fundamen-
tally altered. The Carter administration supported serious
legislation to contain hospital costs, but was defeated by a combina-
tion of hospital lobbyists, distrust of Carter's team, and doubt as to
whether the federal government could accomplish what it promised.
Inflation continued unabated amid drivel about a voluntary effort to
control costs by the health industry as a new set of actors came to
play much more important roles in American medicine.
Attracted by the gold mine of funds flowing through a system of
retrospective, cost-based reimbursement, the captains of American
capitalism saw opportunity where the politicians saw only cause for
complaint. In the hospital world itself, small chains of for-profit
hospitals-the Humanas and Hospital Corporations of America, to
name the most prominent examples concentrated in the South-
grew into large companies throughout the disappointing regulatory
decade of the 70's. The growth of Health Maintenance Organiza-
tions (HMOs)-slower than promised by the enthusiasts of the
1973 authorizing legislation--came to include for-profit firms as
well. Industrial giants, such as Baxter-Travenol and American
Hospital Supply, took their conventional ideas of competitive
growth and extended them to vertical and horizontal integration. A
growing glut of physicians weakened the traditional power of doc-
tors to determine their own terms of work.
All of these changes in the structure of American medicine took
place within the context of increasingly antiregulatory and anti-
Washington rhetoric. Both Democrats and Republicans had been
influenced by a generation of academic policy analysts (mostly
economists) who ridiculed the regulatory costliness and the cap-
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tured quality of decisions of the independent regulatory agencies in
Washington. The Civil Aeronautics Board and the airlines industry
came to epitomize the distortions that are likely to occur when gov-
ernments regulate industries. With time, the convention of describ-
ing any set of related activities with economic significance as an
"industry" demythologized medicine as well. So even before the
Reagan administration came into office, the time was ripe for cele-
brating "competition" in medicine, getting government off the in-
dustry's back, and letting the fresh air of deregulation solve the
problems of access, cost, and quality.
The irony is that the most consequential health initiative of the
Reagan period- Medicare's prospective payment system of diagno-
sis-related groups (DRGs)-is an exceedingly sophisticated, highly
regulatory form of administered prices that changes the incentives
facing hospitals. The further irony is that medical inflation has
somewhat declined just at the time that the massive federal deficit
makes unthinkable a direct attack on the problem represented by
the thirty to forty million Americans who lack anything resembling
adequate health insurance. So fifteen years after talk of a medical
world in critical condition, the problem of access continues to be
serious, the relative rate of inflation has slowed slightly, and truly
extraordinary changes in the rules of the professional game are tak-
ing place as American capitalism flexes its muscles in the $400 bil-
lion industry that once was called medicine.3
At one extreme in the debate over public health expenditures is
the idea of complete government control over and administration of
medical care. Some Americans-policymakers and medical care
professionals as well as ordinary citizens-think that the only way
to control the problems of America's health care system would be
to follow something like the British National Health Service. That
model, however, invokes the unhappy image of the rationing of care
and long waits for all but the most pressing medical problems.' It
also conjures up images of "socialized" medicine, with all the loss of
individual control and freedom of choice for both practitioner and
3. For a varied discussion of these new elements in American medicine, see Goldsmith,
Death of a Paradigm: The Challenge of Competition, 3 HEALTH AFF., Fall 1984, at 7; P.
STARR, THE SOCIAL TRANSFORMATION OF AMERICAN MEDICINE (1984); and Marmor,
Schlesinger & Smithey, A New Look at Nonprofits: Health Policy in a Competitive Age, 3
YALE J. ON REG. 313 (1986).
4. See, e.g., H. AARON & W. SCHWARTZ, THE PAINFUL PRESCRIPTION: RATIONING
HEALTH CARE (1983). For a critique of the Aaron and Schwartz use of the British experi-
ence, see Marmor & Klein, Cost vs. Care: America's Health Care Dilemma Wrongly Consid-
ered, 4 HEALTH MATRIX, Spring 1986, at 19, 19-24.
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consumer that those words connote. The seriousness of American
medicine's current problems, as Professor Wing's article correctly
notes, does not mean there is concomitant widespread public sup-
port for implementing either the British system or the Canadian
version of national health insurance in America.
At the other extreme in American health policy debates is a set
of ideas known as the "competitive health strategy." Though their
arguments vary, advocates of competition believe that restructuring
market incentives is crucial to restraining medical care expenditure
increases and, thus, government health outlays. They argue that
the key to reducing medicine's expenditures is the introduction of
greater price competition in the delivery of care. In light of wide-
spread health insurance, the scope for price competition is greater
for premiums than for fees and charges through substantially in-
creased consumer cost-sharing. The striking feature of this perspec-
tive is the gap between the rhetoric of competition and the reality of
the constraints on the room to maneuver.
A significant impediment to the enactment of pro-competitive
legislation is the imprecise connection between effective competitive
markets and reductions in medical care expenditures. A competi-
tive strategy, even if implemented, does not necessarily produce vis-
ible economic gains. Even its most optimistic supporters concede
that it would take ten to fifteen years for a competitive market to
develop and, if effective, to begin to reduce medical expenditures in
any given area. During the developmental period, medical care ex-
penditures would continue to increase, as would pressure on politi-
cians to "do something." Lastly, the eventual outcome of a
competitive strategy is uncertain, since it has not been implemented
anywhere on a wide scale in the post-war period. For these reasons,
all touched on in Professor Wing's article, the reality of health poli-
tics in the 1980's is one of incremental steps of both a regulatory
and competitive variety. It is a state of what one might call "agi-
tated incrementalism." 5
Professor Wing's magisterial article addresses two aspects of
this melancholy tale. First, he describes the size of the health sec-
tor's financial outlays over the past two decades, disaggregates these
expenditures into their component parts, and tries to make sense of
the composition of American health spending. Second, he attempts
to explain politically why this state of affairs transpired. That in-
5. These ideas are drawn from T.R. MARMOR & J. CHRISTIANSON, HEALTH CARE
POLICY ECONOMY APPROACH 220-29 (1982).
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volves characterizing the national apprehension of the so-called
health cost crisis and simultaneously accounting for the discrepancy
between the rhetoric of concern and the reality of unsystematic,
marginal reforms in how we pay, and how much we pay, for medi-
cal care. Professor Wing is eminently successful with the first task
and moderately successful with the second.
Professor Wing's treatment of the politics of medical inflation is
relatively straightforward, but extended in exposition. There is lit-
tle public concern, he argues, about the rising costs of health care in
the United States. Rather, the concern that does exist, he correctly
states, deals with the cost of care in more parochial senses. Individ-
uals are concerned with the cost of premiums or cost-sharing. Em-
ployers worry about increased expenditures for employee health
insurance. Governments voice concern about rising outlays for
public programs: Medicare and Medicaid in the federal context,
and Medicaid in the state arena. Relative inflation in medical
care-the concern that society is spending increasingly more for
care in the aggregate than its citizens receive in benefits-is an aca-
demic's problem rather than a public concern. The result, as Brian
Abel-Smith wrote some years ago, is an America where we receive
insufficient "value for money. "6
The implication Professor Wing draws is this. If cost contain-
ment is attempted, it will likely be aimed at controlling the federal
government's rising expenditures for health care. The problem with
that approach, he astutely notes, is the obvious one that actions
which save federal dollars-for Medicare, Medicaid, or other health
programs-are not necessarily anti-inflationary successes. Rather
than decrease total spending, such policies may only succeed in sub-
stantially shifting costs from the federal government to other
payors. Equally worrisome is the possibility that reduced federal
outlays may be obtained from the denial of care, rather than from
the streamlining of care through providing similar services at less
cost, or more services at the same price per unit, or more health
results at given prices. Budget deficit reduction, in short, is a goal
that can be reached by a variety of means, only some of which meet
acceptable criteria for national health policy.
I take this to be true and easily defended. Indeed, I have so
argued in a number of places.7 Professor Wing makes his case ex-
6. B. ABEL-SMITH, VALUE FOR MONEY IN HEALTH SERVICES (1976).
7. See, e.g., MARMOR, WITTMAN & HEAGY, The Politics ofMedical Inflation, in T.R.
MARMOR, POLITICAL ANALYSIS AND AMERICAN MEDICAL CARE 61 (1983); Marmor &
Dunham, The Politics ofHealth Policy Reform: Problems, Origins, Alternatives, and a Possi-
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tensively, drawing upon the details of medical prices and outlays
regularly distributed by the Department of Health and Human
Services. If there is any problem with his presentation on this point,
it is what I would politely call legal long-windedness--quite evident
from the number of pages taken to establish an important but not
overly complicated claim about the character of the politics of med-
ical inflation.
Professor Wing spends far more time characterizing medical in-
flation and its political expression than explaining these phenomena.
He strenuously emphasizes, correctly, that there is no consensus
whatsoever regarding either the composition of the problem of ris-
ing medical costs or its possible solutions. He observes that there is
a "divisive political struggle among interest groups in which defin-
ing the nature of the problem is as much in controversy as in fash-
ioning a remedy, and in which the reform or remedy sought for one
problem, as frequently as not, could only exacerbate the problems
of the others." This is as accurate a description of the past fifteen
years of health politics as I know. "The reasons for this political
state of affairs," Professor Wing readily admits, "are not altogether
clear." It is quite true that the delivery of medical care can be si-
multaneously "described as a system on the brink of crisis and as a
strong and growing industry, with equal levels of accuracy."
The elements of an explanation for this state of affairs are
touched on in this Commentary. Professor Wing correctly empha-
sizes the enormous influence of providers in the imbalanced polit-
ical marketplace of health policy. Exacerbating the imbalance is the
lack of sustained public opinion marshalled around any one of the
various formulations of the cost, access, and quality problems of
American medicine. Surely, a very large measure of the explana-
tion for this state of affairs is the pluralism of American politics and
the parallel dispersion of countervailing power in both the political
and economic market places. Our federalism has spread the author-
ity for regulating medical care between the national government
and the many states. Our method of financing medical care differ-
entiates between private and public payors, and there is also consid-
erable variation within each sector itself.
Two explanatory factors, then, become central. Medical care is
a merit good, widely insured through employment, a part of the
ble Prescription, in HEALTH CARE: How TO IMPROVE IT AND PAY FOR IT 33 (1985);
Marmor & Klein, Cost vs. Care: America's Health Care Dilemma Wrongly Considered, 4
HEALTH MATRIX, Spring 1986, at 19.
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private and public welfare state we have fashioned in America. The
fragmentation of finance has resulted in a shift in focus from global
concerns to narrow self interest. Once payors are aroused, the
problem each separately addresses is that of their own costs, not of
American medicine in general. Pluralistic finance, combined with
extensive third-party health coverage, is a predictable recipe for
medical inflation. Only those regimes that have concentrated the
stakes of medical payors-Great Britain, Canada, and France, for
instance-have been able to restrain the forces of medical inflation.
And such countervailing power is but the necessary condition for
restraint; it does not ensure restraint. In some cases, as in Sweden,
the stakeholders with concentrated authority have chosen to spend
more, instead of less, on medical care. But they have made such
choices through balancing the gains and losses of expenditures. In
the United States, we have discovered, rather than chosen, our in-
flating health outlays. How this came to be the case is illuminated
by Professor Wing's extensive essay.
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